Trial Profile
Immunomodulatory Effects of Maraviroc Intensification in HIV-infected Individuals with Incomplete CD4+ T Cell Recovery during Suppressive Antiretroviral Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2011
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- 21 Mar 2011 New trial record
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.